An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk

Recommendations for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal ulceration and cardiovascular (CV) complications were recently made available through an initiative designed in collaboration with leading specialists in South Africa. The prevention of CV comp...

Full description

Saved in:
Bibliographic Details
Main Author: Jacky van Schoor
Format: Article
Language:English
Published: AOSIS 2014-07-01
Series:South African Family Practice
Subjects:
Online Access:https://safpj.co.za/index.php/safpj/article/view/4191
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849234225003233280
author Jacky van Schoor
author_facet Jacky van Schoor
author_sort Jacky van Schoor
collection DOAJ
description Recommendations for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal ulceration and cardiovascular (CV) complications were recently made available through an initiative designed in collaboration with leading specialists in South Africa. The prevention of CV complications and NSAID-related ulceration are discussed in two articles for the purposes of this publication. The first article in this two-part series presented an update on NSAID-related CV risk. This is the second article, and provides an update on NSAIDs and gastrointestinal risk.
format Article
id doaj-art-2a7bae416ffd4fa9b6fe731c79cda271
institution Kabale University
issn 2078-6190
2078-6204
language English
publishDate 2014-07-01
publisher AOSIS
record_format Article
series South African Family Practice
spelling doaj-art-2a7bae416ffd4fa9b6fe731c79cda2712025-08-20T04:03:13ZengAOSISSouth African Family Practice2078-61902078-62042014-07-0156410.4102/safp.v56i4.41913379An update on nonsteroidal anti-inflammatory drugs and gastrointestinal riskJacky van Schoor0Amayeza Info ServicesRecommendations for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal ulceration and cardiovascular (CV) complications were recently made available through an initiative designed in collaboration with leading specialists in South Africa. The prevention of CV complications and NSAID-related ulceration are discussed in two articles for the purposes of this publication. The first article in this two-part series presented an update on NSAID-related CV risk. This is the second article, and provides an update on NSAIDs and gastrointestinal risk.https://safpj.co.za/index.php/safpj/article/view/4191nsaidsgastrointestinal risknonsteroidal anti-inflammatory drugsupdate
spellingShingle Jacky van Schoor
An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk
South African Family Practice
nsaids
gastrointestinal risk
nonsteroidal anti-inflammatory drugs
update
title An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk
title_full An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk
title_fullStr An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk
title_full_unstemmed An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk
title_short An update on nonsteroidal anti-inflammatory drugs and gastrointestinal risk
title_sort update on nonsteroidal anti inflammatory drugs and gastrointestinal risk
topic nsaids
gastrointestinal risk
nonsteroidal anti-inflammatory drugs
update
url https://safpj.co.za/index.php/safpj/article/view/4191
work_keys_str_mv AT jackyvanschoor anupdateonnonsteroidalantiinflammatorydrugsandgastrointestinalrisk
AT jackyvanschoor updateonnonsteroidalantiinflammatorydrugsandgastrointestinalrisk